“Watch the full recording above to hear directly from Dale Atkinson and his care team. The executive summary below highlights key themes from our panel discussion, How Dale Atkinson and His Care Team Navigated Cancer with Personalized Medicine.”
Executive Summary
This webinar brought together patient advocate Dale Atkinson and his multi-disciplinary care team to explore how personalized medicine, precision oncology, nutrition, and repurposed drugs can complement conventional cancer care. The session offered both an inspiring personal story and practical insights into how patients and clinicians can work together to design tailored treatment strategies.
Dale Atkinson, diagnosed with stage IV oesophageal adenocarcinoma in 2024, shared how he refused to accept limited options and instead built a team around him who worked collaboratively to personalize his treatment plan based on his unique cancer profile. In the discussion, Dale described his journey from diagnosis to today, where integrative strategies, next-generation sequencing, and targeted interventions have become central to his care. Alongside Dale, panelists Dr. Hariharan Kuhan, Dr. Padman Vamadevan, Jane McLelland, and Amanda King reflected on their roles in shaping his protocol and shared broader lessons on how precision medicine, metabolic oncology, and nutritional support can empower patients. Together, the panel highlighted the future of oncology as one where patient voices, innovative science, and multi-disciplinary collaboration converge.
Meet the Panel
The conversation was enriched by perspectives from Dale’s care team and collaborators:
- Dale Atkinson – cancer patient, advocate, educator
- Dr. Hariharan Kuhan – medical oncologist with specialist expertise in early phase trials and drug repurposing
- Jane McLelland – expert in metabolic oncology and author of the international bestseller How to Starve Cancer
- Dr. Padman Vamadevan – expert in precision oncology and co-founder of Astron Health
- Amanda King, ND – integrative metabolic oncology nutritionist, tailoring nutrition and complementary therapies to each patient
Key Themes from the Conversation
- Dale’s Journey: From an initial stage IV diagnosis with few conventional options, Dale researched, networked, and ultimately created a personalized treatment plan combining NHS oncology care with metabolic, nutritional, and repurposed drug strategies.
- Team-Based Care: The panel emphasized the importance of collaboration—oncologists, nutritionists, researchers, and patient advocates all play complementary roles in building protocols that are safe, evidence-informed, and patient-centered.
- Precision Medicine: Dr. Vamadevan explained how Astron Health’s genomic and bioinformatic analysis goes beyond conventional oncology, helping clinicians identify vulnerabilities across hundreds of potential cancer driver genes.
- Metabolic Approaches: Jane McLelland and Amanda King highlighted how lifestyle, diet, supplements, and metabolic strategies can shift the cancer microenvironment, improve treatment tolerability, and give patients more agency.
- Oncology’s Future: The group discussed the limitations of one-size-fits-all clinical trials, and the potential for AI, molecular testing, and real-world data to accelerate more personalized, effective care.
- Patient Empowerment: Above all, the panel reinforced that patients can—and should—self-advocate, build supportive teams, and explore safe, evidence-based options beyond standard protocols.
Astron advances precision oncology through data-driven research, providing specialized reports to patients under oncologist supervision when our insights may benefit treatment decisions. Patients should discuss with their clinician whether an Astron Report could support their care, or we can connect them with qualified oncologists familiar with our platform. Clinicians interested in collaboration opportunities can contact support@astron.health.
Astron Health Blog 
Leave a comment